For instance, the expression of SLC7A11 is reduced in esophageal and lung cancers through the interaction of mutant p53 with the transcription factor Nrf2, hence provoking an accumulation of ROS and the activation of ferroptosis [266]. This evidence concerns the gene TP53 and lung carcinoma.